November 13, 2012
R&D Council Selects
Edison Patent Award Winners for 2012 and Celebrates 50th
Anniversary Special Awards
Kicking off its 50th
Anniversary celebration this year, the Research &
Development Council of New Jersey is pleased to announce
that over 30 inventors and thirteen New Jersey companies and
universities have been awarded with the organization’s coveted
Edison Patent Award. Applied Communication Sciences, Avaya,
Alcatel-Lucent Bell Labs, Bristol-Myers Squibb, ExxonMobil
Research & Engineering Company, Honeywell, Immunomedics,
Merck Research Laboratories, NJIT, Rutgers, Siemens
Corporation, Corporate Research & Technology, TE
Connectivity SubCom and UMDNJ have been recognized for
innovative patent work spanning 13 categories, including:
agriculture, biotechnology, emerging technology, enabling
technology, industrial processes, materials technology,
medical device, medical diagnostic, medical imaging,
pharmaceutical, pharmaceutical process, and
telecommunications.
“We are thrilled to honor such significant and interesting
patent work for the Council’s 50th Anniversary,” says Ian
Shankland, Vice President and Chief Technology Officer of
Honeywell Performance Materials and Technologies, and
Chairman of the R & D Council of New Jersey. “When you think
of the tremendous history that New Jersey has in innovation,
dating back to Thomas Edison in the late 1800s, the Council
is fairly young at 50 years, but we have accomplished a lot
during this time and we are excited to celebrate this
milestone.”
Along with the patent awards, a posthumous honor will be
given to Jeffrey Beck, Ph.D., who was a scientist and
researcher at ExxonMobil. Dr. Beck is the recipient of the
Council’s Science & Technology Medal, which is awarded to an
individual for outstanding and unparalleled advancements in
the fields of science and technology, with extraordinary
performance in bringing innovation from the laboratory to
the marketplace. Dr. Beck’s selection for this award was
based on his outstanding contributions to the discovery and
commercialization of novel catalysts and processes for the
production of key petrochemicals and clean fuels.
Sol J. Barer, Ph.D. will receive the Chairman’s Award in
2012. Dr. Barer was selected for his leadership at Celgene
Corporation, coupled with his public service as the Chairman
of the UMDNJ Governor’s Advisory Committee and as a
Commissioner of the NJ Commission on Science and Technology.
Joseph A. Barone, Pharm.D., will be honored as the 2012
Educator of the Year. Dr. Barone is Acting Dean and
Professor at Rutgers’ Ernest Mario School of Pharmacy. He
was selected for this honor for his accomplishments as both
a leader and educator at one of the most prestigious
pharmacy programs in the country. 45 Academy Street, Suite
503 Newark, NJ 07102 973.274.8336 www.rdnj.org
This year’s award winners were honored at the Council’s
50th Anniversary Celebration & 33rd Edison Patent Award
Ceremony & Reception held on November 8, 2012 at the Liberty
Science Center, home to the nation’s largest IMAX Theater,
where an original film highlighted each patent and its
inventors.
Council President Anthony Cicatiello says, “For decades now,
the Council has made it a priority to recognize the
contributions of New Jersey researchers from academia,
industry and government laboratories, and this year is in
keeping with that tradition. The individuals and inventors
being honored are changing the world, and we want everyone
in New Jersey to recognize the significance of their work
and share in their pride. The Patent Awards Ceremony is the
Council’s way of showing our appreciation and recognition of
these talented individuals and the organizations that
support them.”
2012
EDISON PATENT AWARD WINNING PATENTS
AND INVENTORS
Alcatel-Lucent Bell Labs and
inventors Carl Nuzman and Gerhard
Kramer (now at the
Technical University in Munich) will
receive a patent award in the
telecommunications category for
“Simultaneous Estimation of Multiple
Channel Coefficients Using a Common
Probing Sequence” (U.S. Patent
8,218,419), an invention that is a
pilot-based training scheme that
significantly expedites cross-talk
estimation for vectored DSL systems
using joint estimation over group
tones. Vectoring DSL systems will
allow service providers to provide
premium broadband services much
sooner and at a much lower cost than
would be possible using optical
fiber alone.
Applied Communication
Sciences and inventors Thomas
Chapuran, Matthew Goodman, Nicholas
Peters, and Robert Runser
will receive a patent award in the
emerging technology category for
“Distributable Quantum Relay
Architecture” (U.S. Patent
8,103,172), an invention that
enables the use of widely
distributed quantum relay or
repeater stations along a fiber
communications link or network to
significantly increase the distance
over which quantum communications
can be established in a practical
network.
Avaya and inventors Birgit
Geppert and Frank Roessler
will receive a patent award in the
information technology category for
“Telecommunications Endpoint for
Managing Multi-Conferencing” (U.S.
Patent 7,995,733), an invention that
allows teleconferencing users to
simultaneously manage multiple
conference calls, move participants
from one conference call to another
and subdivide or join multiple
conference calls together.
Bristol-Myers Squibb and
inventors Divyakant Desai and Bing
Li will receive a patent
award in the pharmaceutical category
for "Coated Tablet Formulation and
Method” (U.S. Patent 7,951,400), an
invention that relates to the
formulation development of
saxagliptin and its fixed dose
combinations with metformin, which
together offer an advance in the
treatment of Type 2 diabetes.
ExxonMobil Research and
Engineering Company (EMRE) and sole
inventor James M. Brown
were selected for a patent award in
the industrial process category for
“Method for Analyzing an Unknown
Material as a Blend of Known
Materials Calculated so as to Match
Certain Analytical Data and
Predicting Properties of the Unknown
Based on the Calculated Blend” (U.S.
Patent 6,662,116). This work patents
a novel method for rapidly and
accurately assessing the important
chemical properties of crudes from
different reservoirs using
spectroscopic techniques and
predictive algorithms. The method is
useful in deciding how best to
refine the crude.
Honeywell Performance
Materials and Technologies and
inventor Scott Hacker will
be recognized in the materials
technology category for “Maleated
Polypropylenes and Processed for the
Preparation Thereof” (U.S. Patent
7,256,236), an invention that
discloses methods for advantageously
producing maleated polypropylenes
having a relatively high percentage
of bound maleic anhydride, based on
the total amount present in the
grafting reaction product.
Immunomedics and inventors
Chien-Hsing Chang, Ph.D., David M.
Goldenberg, Sc.D., M.D., William J.
McBride, Ph.D., Edmund A. Rossi,
Ph.D., will receive a
patent award in the biotechnology
category for “Stably Tethered
Structures of Defined Compositions
with Multiple Functions of Binding
Sites” (U.S. Patent 7,521,056).
Termed the Dock-and-Lock™ method
(DNL™), this is a protein
engineering platform technology for
the rapid and facile creation of a
wide variety of active biological
agents designed for biotechnological
and biomedical applications.
Merck Research Laboratories
and inventors Karel M. Jos Brands,
Joseph Payack, and Phillip Pye
will be recognized with a patent
award in the pharmaceutical process
category for “Process for the
Synthesis of (2R,
2-alpha-R)-4-Benzyl-2-[-1-(3,5-bis(triflouromethyl)phenyl)ethoxy]-1,4-oxazine-3-one”
(U.S. Patent 6,469,164). This
invention is a novel synthetic
organic chemistry methodology for
the synthesis of the title compound,
which is a key intermediate in an
economically beneficial and
environmentally benign process for
the manufacture of aprepitant, the
active ingredient in Emend.
New Jersey Institute of
Technology’s “No Clog Shunt Using a
Compact Fluid Drag Path” (U.S.
Patent 8,088,091) invented by
Professors Reginald Farrow and
Gordon Thomas and former graduate
student Sheng Liu, will
receive a patent award in the
medical device category. This
implantable device enables wireless
monitoring of both the extremely
slow flow of the cerebrospinal fluid
as well as tiny changes in the
pressure in a shunt that drains
fluid out of the brain. Existing
shunts give no information about the
patients’ health, but are used by
patients suffering from severe
excess pressure in the brain due to
hydrocephalus or brain injury.
Rutgers, The State
University of New Jersey will be
recognized in the agriculture
category for “Male Asparagus Hybrid
Plant ‘NJ953’” (U.S. Patent
PP21,170), invented by Chee-kok
Chin, Stephen Garrison and John
Kinelski. This asparagus is
an all-male hybrid that can be grown
in both warm and cool climates, is
highly resistant to ruse and
tolerant to Fusarium crown and root
rot, and also has very good spear
quality.
Siemens Corporation,
Corporate Research & Technology and
sole inventor Leo Grady, Ph.D.
(who has since taken a position
outside the organization), will
receive a patent award in the
medical imaging category for “System
and Method for Multi-Label Image
Segmentation” (U.S. Patent
7,460,709), which introduces a new
algorithm for localizing and
extracting objects of interest from
image data such that the objects
could be measured, quantified or
used for further processing such as
3D visualization which allows for
maximization of medical and
scientific knowledge gained from the
images.
TE Connectivity SubCom and
inventors Robert Gleason
(posthumously), Craig Murphy,
Seymour Shapiro, William Wright, and
Chung-Shin Ma will be
recognized in the enabling
technology category for “Undersea
Communications Cable Having
Centrally Located, Plastic Buffer
Tube” (U.S. Patent 6,349,161), an
invention that describes the design
of an undersea fiber-optic cable
that can use the newer and higher
performance optical fibers without
an increase in background
attenuation caused by micro-bends.
University of Medicine &
Dentistry of New Jersey
will be recognized in the medical
diagnostic category, along with
inventors Linda Brzustowicz, Neda
Gharani, and James Millonig, for
“Compositions and Methods of
Diagnosing Autism” (U.S. Patent
7,629,123). This patent’s research
has, in part, lead to the launch of
the ARISKAutism Risk Assessment Test
by establishing an association
between ENGRAILED HOMEOBOX 2
transcription factor (EN2) and
susceptibility for autism and
related disorders.
|
